531324 — Roselabs Finance Balance Sheet
0.000.00%
- IN₹305.50m
- IN₹353.67m
- IN₹7.26m
Annual balance sheet for Roselabs Finance, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.513 | 0.277 | 0.038 | 0.681 | 1.16 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | 13.4 | 0 |
Total Other Current Assets | |||||
Total Current Assets | 0.513 | 0.277 | 0.038 | 14.1 | 1.17 |
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2.05 | 1.84 | 1.13 | 15.2 | 2.27 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 60.9 | 15.8 | 0.913 | 13.9 | 0.206 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 60.9 | 65 | 44.2 | 59.5 | 49.5 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -58.8 | -63.2 | -43 | -44.4 | -47.3 |
Total Liabilities & Shareholders' Equity | 2.05 | 1.84 | 1.13 | 15.2 | 2.27 |
Total Common Shares Outstanding |